Detalhe da pesquisa
1.
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias.
J Neurol Neurosurg Psychiatry
; 92(11): 1206-1214, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34103344
2.
AMYQ: An index to standardize quantitative amyloid load across PET tracers.
Alzheimers Dement
; 17(9): 1499-1508, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33797846
3.
Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project.
Alzheimers Dement
; 15(10): 1333-1347, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31473137
4.
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid ß burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.
Alzheimers Dement
; 14(5): 634-643, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29156223
5.
Bilingual Primary Progressive Aphasia: A Scoping Review of Assessment and Treatment Practices.
J Alzheimers Dis
; 96(4): 1453-1476, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980666
6.
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration.
Mol Neurodegener
; 17(1): 29, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395770
7.
The Aß1-42/Aß1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aß1-42 alone.
Alzheimers Res Ther
; 14(1): 20, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35105351